Fresenius Kabi Oncology Ltd. v. SEBI (2013) and Delisting Regulations around the World

  • Anjali Karmakar
  • Show Author Details
  • Anjali Karmakar

    Assistant Professor of Law at Techno India University, West Bengal, India

  • img Download Full Paper


The main purpose of listing of shares at stock exchanges is to provide for marketability to the shares of a company. In the case of Fresenius Kabi Oncology Ltd. v. SEBI (2013), allowed the company to delist its shares from the Indian stock market. SEBI challenged the order of the Tribunal allowing them to delist their shares in the Supreme Court. In this case, the due process of law and the required uniformity of law has been imposed. However, the Tribunal had allowed the SEBI to undergo investigation with regard to the investor complaints, it had allowed the company to delist its shares unconditionally. The delisting regulations are getting stringent over the years. From the onset of March, 2021, China renewed their Securities Law, due to which the two Chinese Exchanges have undergone strict restrictions in terms of financial standards. The shell companies have been targeted with this implementation.


Case Comment


International Journal of Law Management and Humanities, Volume 5, Issue 3, Page 2076 - 2079


Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution -NonCommercial 4.0 International (CC BY-NC 4.0) (, which permits remixing, adapting, and building upon the work for non-commercial use, provided the original work is properly cited.


Copyright © IJLMH 2021